Global Oncology Drugs Market Research Report 2024(Status and Outlook)
Report Overview
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report provides a deep insight into the global Oncology Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Drugs market in any manner.
Global Oncology Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Market Segmentation (by Type)
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Market Segmentation (by Application)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Oncology Drugs Market
%li%Overview of the regional outlook of the Oncology Drugs Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report provides a deep insight into the global Oncology Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Drugs market in any manner.
Global Oncology Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Market Segmentation (by Type)
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Market Segmentation (by Application)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Oncology Drugs Market
%li%Overview of the regional outlook of the Oncology Drugs Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncology Drugs
1.2 Key Market Segments
1.2.1 Oncology Drugs Segment by Type
1.2.2 Oncology Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncology Drugs Sales by Manufacturers (2019-2024)
3.2 Global Oncology Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Drugs Sales Sites, Area Served, Product Type
3.6 Oncology Drugs Market Competitive Situation and Trends
3.6.1 Oncology Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Oncology Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLOGY DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Drugs Sales Market Share by Type (2019-2024)
6.3 Global Oncology Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Drugs Price by Type (2019-2024)
7 ONCOLOGY DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Drugs Market Sales by Application (2019-2024)
7.3 Global Oncology Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Drugs Sales Growth Rate by Application (2019-2024)
8 ONCOLOGY DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Oncology Drugs Sales by Region
8.1.1 Global Oncology Drugs Sales by Region
8.1.2 Global Oncology Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Oncology Drugs Basic Information
9.1.2 Roche Oncology Drugs Product Overview
9.1.3 Roche Oncology Drugs Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Oncology Drugs SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Celgene
9.2.1 Celgene Oncology Drugs Basic Information
9.2.2 Celgene Oncology Drugs Product Overview
9.2.3 Celgene Oncology Drugs Product Market Performance
9.2.4 Celgene Business Overview
9.2.5 Celgene Oncology Drugs SWOT Analysis
9.2.6 Celgene Recent Developments
9.3 Novartis
9.3.1 Novartis Oncology Drugs Basic Information
9.3.2 Novartis Oncology Drugs Product Overview
9.3.3 Novartis Oncology Drugs Product Market Performance
9.3.4 Novartis Oncology Drugs SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Oncology Drugs Basic Information
9.4.2 Bristol-Myers Squibb Oncology Drugs Product Overview
9.4.3 Bristol-Myers Squibb Oncology Drugs Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Oncology Drugs Basic Information
9.5.2 Johnson and Johnson Oncology Drugs Product Overview
9.5.3 Johnson and Johnson Oncology Drugs Product Market Performance
9.5.4 Johnson and Johnson Business Overview
9.5.5 Johnson and Johnson Recent Developments
9.6 Merck and Co.
9.6.1 Merck and Co. Oncology Drugs Basic Information
9.6.2 Merck and Co. Oncology Drugs Product Overview
9.6.3 Merck and Co. Oncology Drugs Product Market Performance
9.6.4 Merck and Co. Business Overview
9.6.5 Merck and Co. Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Oncology Drugs Basic Information
9.7.2 AstraZeneca Oncology Drugs Product Overview
9.7.3 AstraZeneca Oncology Drugs Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Pfizer
9.8.1 Pfizer Oncology Drugs Basic Information
9.8.2 Pfizer Oncology Drugs Product Overview
9.8.3 Pfizer Oncology Drugs Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Amgen
9.9.1 Amgen Oncology Drugs Basic Information
9.9.2 Amgen Oncology Drugs Product Overview
9.9.3 Amgen Oncology Drugs Product Market Performance
9.9.4 Amgen Business Overview
9.9.5 Amgen Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Oncology Drugs Basic Information
9.10.2 Eli Lilly Oncology Drugs Product Overview
9.10.3 Eli Lilly Oncology Drugs Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 AbbVie
9.11.1 AbbVie Oncology Drugs Basic Information
9.11.2 AbbVie Oncology Drugs Product Overview
9.11.3 AbbVie Oncology Drugs Product Market Performance
9.11.4 AbbVie Business Overview
9.11.5 AbbVie Recent Developments
9.12 Takeda
9.12.1 Takeda Oncology Drugs Basic Information
9.12.2 Takeda Oncology Drugs Product Overview
9.12.3 Takeda Oncology Drugs Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
9.13 Astellas
9.13.1 Astellas Oncology Drugs Basic Information
9.13.2 Astellas Oncology Drugs Product Overview
9.13.3 Astellas Oncology Drugs Product Market Performance
9.13.4 Astellas Business Overview
9.13.5 Astellas Recent Developments
9.14 Ipsen
9.14.1 Ipsen Oncology Drugs Basic Information
9.14.2 Ipsen Oncology Drugs Product Overview
9.14.3 Ipsen Oncology Drugs Product Market Performance
9.14.4 Ipsen Business Overview
9.14.5 Ipsen Recent Developments
9.15 Sanofi
9.15.1 Sanofi Oncology Drugs Basic Information
9.15.2 Sanofi Oncology Drugs Product Overview
9.15.3 Sanofi Oncology Drugs Product Market Performance
9.15.4 Sanofi Business Overview
9.15.5 Sanofi Recent Developments
9.16 Bayer
9.16.1 Bayer Oncology Drugs Basic Information
9.16.2 Bayer Oncology Drugs Product Overview
9.16.3 Bayer Oncology Drugs Product Market Performance
9.16.4 Bayer Business Overview
9.16.5 Bayer Recent Developments
9.17 Biogen Idec
9.17.1 Biogen Idec Oncology Drugs Basic Information
9.17.2 Biogen Idec Oncology Drugs Product Overview
9.17.3 Biogen Idec Oncology Drugs Product Market Performance
9.17.4 Biogen Idec Business Overview
9.17.5 Biogen Idec Recent Developments
9.18 Teva
9.18.1 Teva Oncology Drugs Basic Information
9.18.2 Teva Oncology Drugs Product Overview
9.18.3 Teva Oncology Drugs Product Market Performance
9.18.4 Teva Business Overview
9.18.5 Teva Recent Developments
9.19 Otsuka
9.19.1 Otsuka Oncology Drugs Basic Information
9.19.2 Otsuka Oncology Drugs Product Overview
9.19.3 Otsuka Oncology Drugs Product Market Performance
9.19.4 Otsuka Business Overview
9.19.5 Otsuka Recent Developments
9.20 Eisai
9.20.1 Eisai Oncology Drugs Basic Information
9.20.2 Eisai Oncology Drugs Product Overview
9.20.3 Eisai Oncology Drugs Product Market Performance
9.20.4 Eisai Business Overview
9.20.5 Eisai Recent Developments
9.21 Merck KGaA
9.21.1 Merck KGaA Oncology Drugs Basic Information
9.21.2 Merck KGaA Oncology Drugs Product Overview
9.21.3 Merck KGaA Oncology Drugs Product Market Performance
9.21.4 Merck KGaA Business Overview
9.21.5 Merck KGaA Recent Developments
9.22 Gilead Sciences
9.22.1 Gilead Sciences Oncology Drugs Basic Information
9.22.2 Gilead Sciences Oncology Drugs Product Overview
9.22.3 Gilead Sciences Oncology Drugs Product Market Performance
9.22.4 Gilead Sciences Business Overview
9.22.5 Gilead Sciences Recent Developments
10 ONCOLOGY DRUGS MARKET FORECAST BY REGION
10.1 Global Oncology Drugs Market Size Forecast
10.2 Global Oncology Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Drugs Market Size Forecast by Region
10.2.4 South America Oncology Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oncology Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Drugs by Type (2025-2030)
11.1.2 Global Oncology Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Drugs by Type (2025-2030)
11.2 Global Oncology Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncology Drugs
1.2 Key Market Segments
1.2.1 Oncology Drugs Segment by Type
1.2.2 Oncology Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncology Drugs Sales by Manufacturers (2019-2024)
3.2 Global Oncology Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Drugs Sales Sites, Area Served, Product Type
3.6 Oncology Drugs Market Competitive Situation and Trends
3.6.1 Oncology Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Oncology Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLOGY DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Drugs Sales Market Share by Type (2019-2024)
6.3 Global Oncology Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Drugs Price by Type (2019-2024)
7 ONCOLOGY DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Drugs Market Sales by Application (2019-2024)
7.3 Global Oncology Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Drugs Sales Growth Rate by Application (2019-2024)
8 ONCOLOGY DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Oncology Drugs Sales by Region
8.1.1 Global Oncology Drugs Sales by Region
8.1.2 Global Oncology Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Oncology Drugs Basic Information
9.1.2 Roche Oncology Drugs Product Overview
9.1.3 Roche Oncology Drugs Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Oncology Drugs SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Celgene
9.2.1 Celgene Oncology Drugs Basic Information
9.2.2 Celgene Oncology Drugs Product Overview
9.2.3 Celgene Oncology Drugs Product Market Performance
9.2.4 Celgene Business Overview
9.2.5 Celgene Oncology Drugs SWOT Analysis
9.2.6 Celgene Recent Developments
9.3 Novartis
9.3.1 Novartis Oncology Drugs Basic Information
9.3.2 Novartis Oncology Drugs Product Overview
9.3.3 Novartis Oncology Drugs Product Market Performance
9.3.4 Novartis Oncology Drugs SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Oncology Drugs Basic Information
9.4.2 Bristol-Myers Squibb Oncology Drugs Product Overview
9.4.3 Bristol-Myers Squibb Oncology Drugs Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Oncology Drugs Basic Information
9.5.2 Johnson and Johnson Oncology Drugs Product Overview
9.5.3 Johnson and Johnson Oncology Drugs Product Market Performance
9.5.4 Johnson and Johnson Business Overview
9.5.5 Johnson and Johnson Recent Developments
9.6 Merck and Co.
9.6.1 Merck and Co. Oncology Drugs Basic Information
9.6.2 Merck and Co. Oncology Drugs Product Overview
9.6.3 Merck and Co. Oncology Drugs Product Market Performance
9.6.4 Merck and Co. Business Overview
9.6.5 Merck and Co. Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Oncology Drugs Basic Information
9.7.2 AstraZeneca Oncology Drugs Product Overview
9.7.3 AstraZeneca Oncology Drugs Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Pfizer
9.8.1 Pfizer Oncology Drugs Basic Information
9.8.2 Pfizer Oncology Drugs Product Overview
9.8.3 Pfizer Oncology Drugs Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Amgen
9.9.1 Amgen Oncology Drugs Basic Information
9.9.2 Amgen Oncology Drugs Product Overview
9.9.3 Amgen Oncology Drugs Product Market Performance
9.9.4 Amgen Business Overview
9.9.5 Amgen Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Oncology Drugs Basic Information
9.10.2 Eli Lilly Oncology Drugs Product Overview
9.10.3 Eli Lilly Oncology Drugs Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 AbbVie
9.11.1 AbbVie Oncology Drugs Basic Information
9.11.2 AbbVie Oncology Drugs Product Overview
9.11.3 AbbVie Oncology Drugs Product Market Performance
9.11.4 AbbVie Business Overview
9.11.5 AbbVie Recent Developments
9.12 Takeda
9.12.1 Takeda Oncology Drugs Basic Information
9.12.2 Takeda Oncology Drugs Product Overview
9.12.3 Takeda Oncology Drugs Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
9.13 Astellas
9.13.1 Astellas Oncology Drugs Basic Information
9.13.2 Astellas Oncology Drugs Product Overview
9.13.3 Astellas Oncology Drugs Product Market Performance
9.13.4 Astellas Business Overview
9.13.5 Astellas Recent Developments
9.14 Ipsen
9.14.1 Ipsen Oncology Drugs Basic Information
9.14.2 Ipsen Oncology Drugs Product Overview
9.14.3 Ipsen Oncology Drugs Product Market Performance
9.14.4 Ipsen Business Overview
9.14.5 Ipsen Recent Developments
9.15 Sanofi
9.15.1 Sanofi Oncology Drugs Basic Information
9.15.2 Sanofi Oncology Drugs Product Overview
9.15.3 Sanofi Oncology Drugs Product Market Performance
9.15.4 Sanofi Business Overview
9.15.5 Sanofi Recent Developments
9.16 Bayer
9.16.1 Bayer Oncology Drugs Basic Information
9.16.2 Bayer Oncology Drugs Product Overview
9.16.3 Bayer Oncology Drugs Product Market Performance
9.16.4 Bayer Business Overview
9.16.5 Bayer Recent Developments
9.17 Biogen Idec
9.17.1 Biogen Idec Oncology Drugs Basic Information
9.17.2 Biogen Idec Oncology Drugs Product Overview
9.17.3 Biogen Idec Oncology Drugs Product Market Performance
9.17.4 Biogen Idec Business Overview
9.17.5 Biogen Idec Recent Developments
9.18 Teva
9.18.1 Teva Oncology Drugs Basic Information
9.18.2 Teva Oncology Drugs Product Overview
9.18.3 Teva Oncology Drugs Product Market Performance
9.18.4 Teva Business Overview
9.18.5 Teva Recent Developments
9.19 Otsuka
9.19.1 Otsuka Oncology Drugs Basic Information
9.19.2 Otsuka Oncology Drugs Product Overview
9.19.3 Otsuka Oncology Drugs Product Market Performance
9.19.4 Otsuka Business Overview
9.19.5 Otsuka Recent Developments
9.20 Eisai
9.20.1 Eisai Oncology Drugs Basic Information
9.20.2 Eisai Oncology Drugs Product Overview
9.20.3 Eisai Oncology Drugs Product Market Performance
9.20.4 Eisai Business Overview
9.20.5 Eisai Recent Developments
9.21 Merck KGaA
9.21.1 Merck KGaA Oncology Drugs Basic Information
9.21.2 Merck KGaA Oncology Drugs Product Overview
9.21.3 Merck KGaA Oncology Drugs Product Market Performance
9.21.4 Merck KGaA Business Overview
9.21.5 Merck KGaA Recent Developments
9.22 Gilead Sciences
9.22.1 Gilead Sciences Oncology Drugs Basic Information
9.22.2 Gilead Sciences Oncology Drugs Product Overview
9.22.3 Gilead Sciences Oncology Drugs Product Market Performance
9.22.4 Gilead Sciences Business Overview
9.22.5 Gilead Sciences Recent Developments
10 ONCOLOGY DRUGS MARKET FORECAST BY REGION
10.1 Global Oncology Drugs Market Size Forecast
10.2 Global Oncology Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Drugs Market Size Forecast by Region
10.2.4 South America Oncology Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oncology Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Drugs by Type (2025-2030)
11.1.2 Global Oncology Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Drugs by Type (2025-2030)
11.2 Global Oncology Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Drugs Market Size Comparison by Region (M USD)
Table 5. Global Oncology Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oncology Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncology Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncology Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2022)
Table 10. Global Market Oncology Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncology Drugs Sales Sites and Area Served
Table 12. Manufacturers Oncology Drugs Product Type
Table 13. Global Oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncology Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Drugs Market Challenges
Table 22. Global Oncology Drugs Sales by Type (Kilotons)
Table 23. Global Oncology Drugs Market Size by Type (M USD)
Table 24. Global Oncology Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oncology Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Oncology Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncology Drugs Market Size Share by Type (2019-2024)
Table 28. Global Oncology Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oncology Drugs Sales (Kilotons) by Application
Table 30. Global Oncology Drugs Market Size by Application
Table 31. Global Oncology Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oncology Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Oncology Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncology Drugs Market Share by Application (2019-2024)
Table 35. Global Oncology Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncology Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oncology Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Oncology Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oncology Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oncology Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oncology Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oncology Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Oncology Drugs Basic Information
Table 44. Roche Oncology Drugs Product Overview
Table 45. Roche Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Oncology Drugs SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Celgene Oncology Drugs Basic Information
Table 50. Celgene Oncology Drugs Product Overview
Table 51. Celgene Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Celgene Business Overview
Table 53. Celgene Oncology Drugs SWOT Analysis
Table 54. Celgene Recent Developments
Table 55. Novartis Oncology Drugs Basic Information
Table 56. Novartis Oncology Drugs Product Overview
Table 57. Novartis Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Oncology Drugs SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Bristol-Myers Squibb Oncology Drugs Basic Information
Table 62. Bristol-Myers Squibb Oncology Drugs Product Overview
Table 63. Bristol-Myers Squibb Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Recent Developments
Table 66. Johnson and Johnson Oncology Drugs Basic Information
Table 67. Johnson and Johnson Oncology Drugs Product Overview
Table 68. Johnson and Johnson Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Johnson and Johnson Business Overview
Table 70. Johnson and Johnson Recent Developments
Table 71. Merck and Co. Oncology Drugs Basic Information
Table 72. Merck and Co. Oncology Drugs Product Overview
Table 73. Merck and Co. Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Merck and Co. Business Overview
Table 75. Merck and Co. Recent Developments
Table 76. AstraZeneca Oncology Drugs Basic Information
Table 77. AstraZeneca Oncology Drugs Product Overview
Table 78. AstraZeneca Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. Pfizer Oncology Drugs Basic Information
Table 82. Pfizer Oncology Drugs Product Overview
Table 83. Pfizer Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Amgen Oncology Drugs Basic Information
Table 87. Amgen Oncology Drugs Product Overview
Table 88. Amgen Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amgen Business Overview
Table 90. Amgen Recent Developments
Table 91. Eli Lilly Oncology Drugs Basic Information
Table 92. Eli Lilly Oncology Drugs Product Overview
Table 93. Eli Lilly Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Recent Developments
Table 96. AbbVie Oncology Drugs Basic Information
Table 97. AbbVie Oncology Drugs Product Overview
Table 98. AbbVie Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AbbVie Business Overview
Table 100. AbbVie Recent Developments
Table 101. Takeda Oncology Drugs Basic Information
Table 102. Takeda Oncology Drugs Product Overview
Table 103. Takeda Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Takeda Business Overview
Table 105. Takeda Recent Developments
Table 106. Astellas Oncology Drugs Basic Information
Table 107. Astellas Oncology Drugs Product Overview
Table 108. Astellas Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Astellas Business Overview
Table 110. Astellas Recent Developments
Table 111. Ipsen Oncology Drugs Basic Information
Table 112. Ipsen Oncology Drugs Product Overview
Table 113. Ipsen Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ipsen Business Overview
Table 115. Ipsen Recent Developments
Table 116. Sanofi Oncology Drugs Basic Information
Table 117. Sanofi Oncology Drugs Product Overview
Table 118. Sanofi Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Sanofi Business Overview
Table 120. Sanofi Recent Developments
Table 121. Bayer Oncology Drugs Basic Information
Table 122. Bayer Oncology Drugs Product Overview
Table 123. Bayer Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Bayer Business Overview
Table 125. Bayer Recent Developments
Table 126. Biogen Idec Oncology Drugs Basic Information
Table 127. Biogen Idec Oncology Drugs Product Overview
Table 128. Biogen Idec Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Biogen Idec Business Overview
Table 130. Biogen Idec Recent Developments
Table 131. Teva Oncology Drugs Basic Information
Table 132. Teva Oncology Drugs Product Overview
Table 133. Teva Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Teva Business Overview
Table 135. Teva Recent Developments
Table 136. Otsuka Oncology Drugs Basic Information
Table 137. Otsuka Oncology Drugs Product Overview
Table 138. Otsuka Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Otsuka Business Overview
Table 140. Otsuka Recent Developments
Table 141. Eisai Oncology Drugs Basic Information
Table 142. Eisai Oncology Drugs Product Overview
Table 143. Eisai Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Eisai Business Overview
Table 145. Eisai Recent Developments
Table 146. Merck KGaA Oncology Drugs Basic Information
Table 147. Merck KGaA Oncology Drugs Product Overview
Table 148. Merck KGaA Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Merck KGaA Business Overview
Table 150. Merck KGaA Recent Developments
Table 151. Gilead Sciences Oncology Drugs Basic Information
Table 152. Gilead Sciences Oncology Drugs Product Overview
Table 153. Gilead Sciences Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. Gilead Sciences Business Overview
Table 155. Gilead Sciences Recent Developments
Table 156. Global Oncology Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 157. Global Oncology Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 158. North America Oncology Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 159. North America Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 160. Europe Oncology Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 161. Europe Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 162. Asia Pacific Oncology Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 163. Asia Pacific Oncology Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 164. South America Oncology Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 165. South America Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Oncology Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 167. Middle East and Africa Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Global Oncology Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 169. Global Oncology Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 170. Global Oncology Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 171. Global Oncology Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 172. Global Oncology Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Drugs Market Size Comparison by Region (M USD)
Table 5. Global Oncology Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oncology Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncology Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncology Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2022)
Table 10. Global Market Oncology Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncology Drugs Sales Sites and Area Served
Table 12. Manufacturers Oncology Drugs Product Type
Table 13. Global Oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncology Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Drugs Market Challenges
Table 22. Global Oncology Drugs Sales by Type (Kilotons)
Table 23. Global Oncology Drugs Market Size by Type (M USD)
Table 24. Global Oncology Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oncology Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Oncology Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncology Drugs Market Size Share by Type (2019-2024)
Table 28. Global Oncology Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oncology Drugs Sales (Kilotons) by Application
Table 30. Global Oncology Drugs Market Size by Application
Table 31. Global Oncology Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oncology Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Oncology Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncology Drugs Market Share by Application (2019-2024)
Table 35. Global Oncology Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncology Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oncology Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Oncology Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oncology Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oncology Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oncology Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oncology Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Oncology Drugs Basic Information
Table 44. Roche Oncology Drugs Product Overview
Table 45. Roche Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Oncology Drugs SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Celgene Oncology Drugs Basic Information
Table 50. Celgene Oncology Drugs Product Overview
Table 51. Celgene Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Celgene Business Overview
Table 53. Celgene Oncology Drugs SWOT Analysis
Table 54. Celgene Recent Developments
Table 55. Novartis Oncology Drugs Basic Information
Table 56. Novartis Oncology Drugs Product Overview
Table 57. Novartis Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Oncology Drugs SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Bristol-Myers Squibb Oncology Drugs Basic Information
Table 62. Bristol-Myers Squibb Oncology Drugs Product Overview
Table 63. Bristol-Myers Squibb Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Recent Developments
Table 66. Johnson and Johnson Oncology Drugs Basic Information
Table 67. Johnson and Johnson Oncology Drugs Product Overview
Table 68. Johnson and Johnson Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Johnson and Johnson Business Overview
Table 70. Johnson and Johnson Recent Developments
Table 71. Merck and Co. Oncology Drugs Basic Information
Table 72. Merck and Co. Oncology Drugs Product Overview
Table 73. Merck and Co. Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Merck and Co. Business Overview
Table 75. Merck and Co. Recent Developments
Table 76. AstraZeneca Oncology Drugs Basic Information
Table 77. AstraZeneca Oncology Drugs Product Overview
Table 78. AstraZeneca Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. Pfizer Oncology Drugs Basic Information
Table 82. Pfizer Oncology Drugs Product Overview
Table 83. Pfizer Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Amgen Oncology Drugs Basic Information
Table 87. Amgen Oncology Drugs Product Overview
Table 88. Amgen Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amgen Business Overview
Table 90. Amgen Recent Developments
Table 91. Eli Lilly Oncology Drugs Basic Information
Table 92. Eli Lilly Oncology Drugs Product Overview
Table 93. Eli Lilly Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Recent Developments
Table 96. AbbVie Oncology Drugs Basic Information
Table 97. AbbVie Oncology Drugs Product Overview
Table 98. AbbVie Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AbbVie Business Overview
Table 100. AbbVie Recent Developments
Table 101. Takeda Oncology Drugs Basic Information
Table 102. Takeda Oncology Drugs Product Overview
Table 103. Takeda Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Takeda Business Overview
Table 105. Takeda Recent Developments
Table 106. Astellas Oncology Drugs Basic Information
Table 107. Astellas Oncology Drugs Product Overview
Table 108. Astellas Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Astellas Business Overview
Table 110. Astellas Recent Developments
Table 111. Ipsen Oncology Drugs Basic Information
Table 112. Ipsen Oncology Drugs Product Overview
Table 113. Ipsen Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ipsen Business Overview
Table 115. Ipsen Recent Developments
Table 116. Sanofi Oncology Drugs Basic Information
Table 117. Sanofi Oncology Drugs Product Overview
Table 118. Sanofi Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Sanofi Business Overview
Table 120. Sanofi Recent Developments
Table 121. Bayer Oncology Drugs Basic Information
Table 122. Bayer Oncology Drugs Product Overview
Table 123. Bayer Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Bayer Business Overview
Table 125. Bayer Recent Developments
Table 126. Biogen Idec Oncology Drugs Basic Information
Table 127. Biogen Idec Oncology Drugs Product Overview
Table 128. Biogen Idec Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Biogen Idec Business Overview
Table 130. Biogen Idec Recent Developments
Table 131. Teva Oncology Drugs Basic Information
Table 132. Teva Oncology Drugs Product Overview
Table 133. Teva Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Teva Business Overview
Table 135. Teva Recent Developments
Table 136. Otsuka Oncology Drugs Basic Information
Table 137. Otsuka Oncology Drugs Product Overview
Table 138. Otsuka Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Otsuka Business Overview
Table 140. Otsuka Recent Developments
Table 141. Eisai Oncology Drugs Basic Information
Table 142. Eisai Oncology Drugs Product Overview
Table 143. Eisai Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Eisai Business Overview
Table 145. Eisai Recent Developments
Table 146. Merck KGaA Oncology Drugs Basic Information
Table 147. Merck KGaA Oncology Drugs Product Overview
Table 148. Merck KGaA Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Merck KGaA Business Overview
Table 150. Merck KGaA Recent Developments
Table 151. Gilead Sciences Oncology Drugs Basic Information
Table 152. Gilead Sciences Oncology Drugs Product Overview
Table 153. Gilead Sciences Oncology Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. Gilead Sciences Business Overview
Table 155. Gilead Sciences Recent Developments
Table 156. Global Oncology Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 157. Global Oncology Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 158. North America Oncology Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 159. North America Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 160. Europe Oncology Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 161. Europe Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 162. Asia Pacific Oncology Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 163. Asia Pacific Oncology Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 164. South America Oncology Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 165. South America Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Oncology Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 167. Middle East and Africa Oncology Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Global Oncology Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 169. Global Oncology Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 170. Global Oncology Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 171. Global Oncology Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 172. Global Oncology Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncology Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Drugs Market Size (M USD), 2019-2030
Figure 5. Global Oncology Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Oncology Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Drugs Market Size by Country (M USD)
Figure 11. Oncology Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Oncology Drugs Revenue Share by Manufacturers in 2023
Figure 13. Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncology Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncology Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncology Drugs Market Share by Type
Figure 18. Sales Market Share of Oncology Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Oncology Drugs by Type in 2023
Figure 20. Market Size Share of Oncology Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Oncology Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncology Drugs Market Share by Application
Figure 24. Global Oncology Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Oncology Drugs Sales Market Share by Application in 2023
Figure 26. Global Oncology Drugs Market Share by Application (2019-2024)
Figure 27. Global Oncology Drugs Market Share by Application in 2023
Figure 28. Global Oncology Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncology Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oncology Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oncology Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oncology Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oncology Drugs Sales Market Share by Country in 2023
Figure 37. Germany Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oncology Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oncology Drugs Sales Market Share by Region in 2023
Figure 44. China Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oncology Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Oncology Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oncology Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oncology Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oncology Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oncology Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oncology Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oncology Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Oncology Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Oncology Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Oncology Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Drugs Market Size (M USD), 2019-2030
Figure 5. Global Oncology Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Oncology Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Drugs Market Size by Country (M USD)
Figure 11. Oncology Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Oncology Drugs Revenue Share by Manufacturers in 2023
Figure 13. Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncology Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncology Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncology Drugs Market Share by Type
Figure 18. Sales Market Share of Oncology Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Oncology Drugs by Type in 2023
Figure 20. Market Size Share of Oncology Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Oncology Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncology Drugs Market Share by Application
Figure 24. Global Oncology Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Oncology Drugs Sales Market Share by Application in 2023
Figure 26. Global Oncology Drugs Market Share by Application (2019-2024)
Figure 27. Global Oncology Drugs Market Share by Application in 2023
Figure 28. Global Oncology Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncology Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oncology Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oncology Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oncology Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oncology Drugs Sales Market Share by Country in 2023
Figure 37. Germany Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oncology Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oncology Drugs Sales Market Share by Region in 2023
Figure 44. China Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oncology Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Oncology Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oncology Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oncology Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oncology Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oncology Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oncology Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oncology Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oncology Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Oncology Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Oncology Drugs Market Share Forecast by Application (2025-2030)
